Senzime announced the contract and first deliveries of TetraGraph systems to one of USA's leading private healthcare providers and not-for-profit health plans. The Integrated Delivery Network (IDN) serves several million members mainly on the US West Coast. The TetraGraph is the first portable electromyography (EMG)-based neuromuscular monitor on the market that is clinically validated and meets new clinical guidelines published by ASA (American Society of Anesthesiologists) and ESAIC (European Society of Anaesthesiology and Intensive Care).

Since its market introduction in 2019, the TetraGraph has been installed at hundreds of leading hospitals across the globe. The TetraGraph system is used during surgery to monitor the patient's level of neuromuscular blockade accurately. This helps anaesthesiologists secure the right dose of neuromuscular blocking drugs and indicate when it is safe to allow patients to breathe on their own, and thereby avoid serious complications and increase healthcare efficiency.